Long-term anatomical and functional outcomes after switch to aflibercept therapy for neovascular age-related macular degeneration

被引：0
|
作者：
Chae, Bora [1 ]
Barbazetto, Irene [1 ,2 ]
Gallego-Pinazo, Roberto [2 ,3 ]
Patel, Samir [4 ]
机构：
[1] NYU, Sch Med, Ophthalmol, New York, NY USA
[2] Vitreous Retina Macula Consultants New York, New York, NY USA
[3] Univ & Polytech Hosp La Fe, Ophthalmol, Valencia, Spain
[4] Weill Cornell Med Coll, New York, NY USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2015年 / 56卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4588
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Long-term anatomical and functional outcomes in patients with neovascular age-related macular degeneration (nAMD) after switching from Ranibizumab to Aflibercept therapy
    Christou, Louise
    Kirthi, Varo
    Peregrine, Helen
    Essaji, Fariha
    Canning, Sarah
    Ioannidis, Pantelis
    Kashani, Shahram
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [2] Long-Term Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration in a Clinical Setting
    Eleftheriadou, Maria
    Vazquez-Alfageme, Clara
    Citu, Cristina Maria
    Crosby-Nwaobi, Roxanne
    Sivaprasad, Sobha
    Hykin, Philip
    Hamilton, Robin D.
    Patel, Praveen J.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 174 : 160 - 168
  • [3] Long-term Outcomes of Aflibercept Treatment for Neovascular Age-related Macular Degeneration in a Clinical Setting
    Calugaru, Dan
    Calugaru, Mihai
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 174 : 185 - 186
  • [4] LONG-TERM OUTCOMES OF SWITCHING TO AFLIBERCEPT FOR TREATMENT RESISTANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Spooner, Kimberly
    Hong, Thomas
    Nair, Rashmi
    Chow, Nicholas Chian Chiang
    Broadhead, Geoffrey
    Wijeyakumar, Wijeyanthy
    Chang, Andrew
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [5] Long-term outcomes of switching to aflibercept for treatment-resistant neovascular age-related macular degeneration
    Spooner, Kimberly
    Hong, Thomas
    Nair, Rashmi
    Chow, Nicholas Chian Chiang
    Broadhead, Geoffrey K.
    Wijeyakumar, Wijeyanthy
    Chang, Andrew A.
    ACTA OPHTHALMOLOGICA, 2019, 97 (05) : E706 - E712
  • [6] Long-term Outcomes of Aflibercept Treatment for Neovascular Age-related Macular Degeneration in a Clinical Setting REPLY
    Eleftheriadou, Maria
    Vazquez-Alfageme, Clara
    Citu, Cristina Maria
    Crosby-Nwaobi, Roxanne
    Sivaprasad, Sobha
    Hykin, Philip
    Hamilton, Robin D.
    Patel, Praveen J.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 174 : 186 - 186
  • [7] THE INFLUENCE OF VITREOMACULAR ADHESION ON OUTCOMES AFTER AFLIBERCEPT THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    McKibbin, Martin A.
    Suter, Carlo A.
    Willis, Thomas A.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (10): : 1951 - 1956
  • [8] Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration
    Bekir Kü?ük
    Sibel Kaday?f??lar
    Bora Eldem
    International Journal of Ophthalmology, 2018, (04) : 645 - 649
  • [9] Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration
    Kucuk, Bekir
    Kadayifcilar, Sibel
    Eldem, Bora
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2018, 11 (04) : 645 - 649
  • [10] Aflibercept for neovascular age-related macular degeneration
    Sarwar, Salman
    Clearfield, Elizabeth
    Soliman, Mohamed Kamel
    Sadiq, Mohammad Ali
    Baldwin, Andrew J.
    Hanout, Mostafa
    Agarwal, Aniruddha
    Sepah, Yasir J.
    Do, Diana V.
    Quan Dong Nguyen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (02):
12345